Close Menu
Home › Cancer Genetics Q1 Revenues Fall 11 Percent

Cancer Genetics Q1 Revenues Fall 11 Percent

May 21, 2019
|
staff reporter

NEW YORK (GenomeWeb) — Cancer Genetics reported after the close of the market on Monday an 11 percent drop in first quarter revenues as improved performance by its biopharma services operations was more than offset by declines in clinical and discovery services revenues.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
19
Featured Webinar

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Molecular Diagnostics

  1. NCCN Updates Genetic Testing Guidelines for Assessing Breast, Ovarian, Pancreatic Cancer Risk

  2. Ambry Genetics, Caris Life Sciences Partner on Cancer Genetic Testing

  3. Illumina, ArcherDx Expand Partnership on NGS IVD Tests

  4. FDA Approves Foundation Medicine CDx for Novartis Breast Cancer Drug Piqray

  5. Veracyte Exclusively Licenses NanoString Diagnostic Platform for Up to $60M

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.